This Newport Beach Medtech Company Has a Plan to Clear the Nation's Coming Spike In Discarded Vaccine Needles

This Newport Beach Medtech Company Has a Plan to Clear the Nation's Coming Spike In Discarded Vaccine Needles

As the country prepares for mass COVID-19 vaccinations, OnSite Waste Technologies is expecting a spike in demand.

The Newport Beach-based company's device quickly sterilizes needles and other biomedical waste, a process that can take clinics and nursing homes over a month as they ship off the hazardous materials to one of the country's several dozen incinerators.

The company saw demand jump as the pandemic left nursing homes and assisted living facilities with piles of waste. Their orders rose 500% between May and July compared to the same quarter last year.

"Waste was storing up in those facilities and they weren't letting the hauling services come in," said Brad Barnes, the startup's co-founder and CEO.

Armed with a $3.5 million Series A round led by Mark IV Capital, the company is readying to ramp up production of their printer-sized device. It sterilizes biomedical waste products like personal protective gear by heating them up to 400 degrees for 90 minutes. The process gets rid of all viruses like COVID-19, bacteria and other spores, allowing the the old products to be disposed of in a trash can.

The company, which launched last year, currently rents its hardware to long-term care facilities and clinics for infusion therapy and male testosterone replacement in 41 states. Barnes said it took a total of three years to receive regulatory approval, which varies for each state.

Offices can run about 200 needles through the sterilization machine during each three-hour cycle. After the machine heats this so-called "red-bag" waste and lets it cool, it's safe enough to throw away with normal trash.

Barnes said switching to his technology can save businesses up to 60% in costs compared to paying for the traditional method of medical waste disposal. It also reduces a company's risk to exposing healthcare workers to infectious diseases.

"If nothing else, it shortens their liability time," he said.

In the last four months the startup has grown its team by 40%, Barnes said, and they're looking to increase it by another 40. The latest round bumps the startup's total funding to $8.5 million.

With roughly 40 million people living in California alone, Barnes is eying opportunity. He sees mobile vaccination units, for example, as potential customers across the country.

"What we see ahead of us is 10 billion new injections that were never expected or planned that'll take place in the next couple of years," he said. "All of us are in for a long haul."

California's acting state public health officer said earlier this week that, while a number of doses might be available by the end of the year, widespread vaccination probably won't be ready for "many more months."

**This story has been updated.

Subscribe to our newsletter to catch every headline.

Art by NicoElNino/ Shutterstock

Between a distinguished career as a U.S. Navy officer and various roles at IT and cybersecurity firms, Glen Day became the Los Angeles County Department of Health Services’ first chief privacy officer in 2002—a role tasked with overseeing HIPAA compliance for over a million medical patients.

At the time, governments and businesses alike were only beginning to understand the importance of privacy in a budding technological world, where data still straddled both analog and digital realms. Two decades later, the evolution of data storage and the cloud have turned companies into data hoarders. As a result, security breaches have become more sophisticated, and privacy compliance—from the European Union’s General Data Protection Regulation rules to California’s “right to be forgotten” law—has only increased.

Read more Show less
Keerthi Vedantam

Keerthi Vedantam is a bioscience reporter at dot.LA. She cut her teeth covering everything from cloud computing to 5G in San Francisco and Seattle. Before she covered tech, Keerthi reported on tribal lands and congressional policy in Washington, D.C. Connect with her on Twitter, Clubhouse (@keerthivedantam) or Signal at 408-470-0776.

Image courtesy of Bored Breakfast Club

While you can’t drink an NFT, that isn’t stopping some beverage startups from looking to capitalize on the blockchain-enabled craze.

Non-fungible tokens have gained traction in the art world, where artists and creators are using the digital assets to create closer connections with fans and collectors.

Read more Show less
Perrin Davidson
Perrin Davidson is the publisher of⁣ LAeats, an L.A.-based food community covering the food industry, food entertainment and food tech.